|
FECH expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62481139653892E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.33066907387547E-15 |
| Normal-vs-Stage2 |
2.660000E-03 |
| Normal-vs-Stage3 |
4.10782519111308E-15 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
4.903500E-03 |
| Stage1-vs-Stage3 |
2.596400E-01 |
| Stage1-vs-Stage4 |
8.00149999999888E-05 |
| Stage2-vs-Stage3 |
1.158840E-03 |
| Stage2-vs-Stage4 |
2.01070000005465E-06 |
| Stage3-vs-Stage4 |
1.921680E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.66133814775094E-16 |
| Normal-vs-AfricanAmerican |
1.27830000029583E-07 |
| Normal-vs-Asian |
1.62458935193399E-12 |
| Caucasian-vs-AfricanAmerican |
5.552000E-01 |
| Caucasian-vs-Asian |
5.020000E-02 |
| AfricanAmerican-vs-Asian |
4.920400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.13009601676595E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
9.780800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
2.44249065417534E-15 |
| Normal-vs-Age(61-80Yrs) |
1.01210000380547E-08 |
| Normal-vs-Age(81-100Yrs) |
1.222620E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.329800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.287700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.111000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.908500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.723400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.546800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.29409999996655E-06 |
| Classical-VS-Follicular |
1.69764999999877E-05 |
| Classical-VS-Other |
5.460600E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
1.91809901295414E-11 |
| Tall-VS-Other |
3.658200E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
6.421600E-02 |
| Follicular-VS-Normal |
4.03340000000307E-05 |
| Other-VS-Normal |
3.60350000000453E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.70360392459656E-11 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.95709999820204E-08 |
|
|
